Pacira BioSciences Inc. PCRX
$22.78
▼ -1.58% 24H
About
Pacira BioSciences Inc. is a biopharmaceutical company dedicated to developing, manufacturing, and commercializing innovative non-opioid pain management therapies. Its primary focus is transforming patient care by providing opioid-sparing alternatives for acute, postsurgical, chronic, and musculoskeletal pain, includin…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees825
TickerPCRX
Statistics
Market Cap$895.5M
Revenue (TTM)$726.4M
Net Income$7.0M
Net Margin1.0%
EPS$0.16
P/E179.69
P/S1.25
P/B1.40
EV/EBITDA9.32
ROE0.7%
Dividend Yield—
Price$22.78
Data: Twelve Data · Revenue = mcap / P/S